Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.
Content published before 2002 is available via pay-per-view purchase only.
Subscribe:
Subscribe to Clinics in Laboratory MedicineAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Biology of natural killer cells.Adv Immunol. 1989; 47: 187-376
- Keeping NK cells in highly regulated antiviral warfare.Trends Immunol. 2007; 28: 252-259
- New aspects of natural-killer-cell surveillance and therapy of cancer.Nat Rev Cancer. 2002; 2: 850-861
- Adaptive immune features of natural killer cells.Nature. 2009; 457: 557-561
- Intrasplenic trafficking of natural killer cells is redirected by chemokines upon inflammation.Eur J Immunol. 2008; 38: 2076-2084
- What does it take to make a natural killer?.Nat Rev Immunol. 2003; 3: 413-425
- Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defence strategy.Nature. 1986; 319: 675-678
- In search of the 'missing self': MHC molecules and NK cell recognition.Immunol Today. 1990; 11: 237-244
- NK cell recognition.Annu Rev Immunol. 2005; 23: 225-274
- Line of attack: NK cell specificity and integration of signals.Curr Opin Immunol. 2008; 20: 344-352
- Natural killer cell receptor signaling.Curr Opin Immunol. 2003; 15: 308-314
- Variable receptors controlling activation and inhibition of NK cells.Curr Opin Immunol. 2002; 14: 615-621
- Human NK-cell receptors.Immunol Today. 2000; 21: 420-422
- Innate or adaptive immunity? The example of natural killer cells.Science. 2011; 331: 44-49
- NK cell receptors.Annu Rev Immunol. 1998; 16: 359-393
- Inhibition of natural killer cell activation signals by killer cell immunoglobulin-like receptors (CD158).Immunol Rev. 2001; 181: 223-233
- Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis.Annu Rev Immunol. 2001; 19: 197-223
- KIR: diverse, rapidly evolving receptors of innate and adaptive immunity.Annu Rev Immunol. 2002; 20: 217-251
- Plasticity in the organization and sequences of human KIR/ILT gene families.Proc Natl Acad Sci U S A. 2000; 97: 4778-4783
- Genetic and functional relationships between MHC and NK receptor genes.Immunity. 2001; 15: 363-374
- Killer-cell immunoglobulin-like receptor (KIR) nomenclature report, 2002.Tissue Antigens. 2003; 62: 79-86
- Human diversity in killer cell inhibitory receptor genes.Immunity. 1997; 7: 753-763
- The killer cell immunoglobulin-like receptor (KIR) genomic region: gene-order, haplotypes and allelic polymorphism.Immunol Rev. 2002; 190: 40-52
- Killer Ig-like receptor haplotype analysis by gene content: evidence for genomic diversity with a minimum of six basic framework haplotypes, each with multiple subsets.J Immunol. 2002; 169: 5118-5129
- Allelic polymorphism synergizes with variable gene content to individualize human KIR genotype.J Immunol. 2002; 168: 2307-2315
- KIR haplotype content at the allele level in 77 Northern Irish families.Immunogenetics. 2007; 59: 145-158
- Variation within the human killer cell immunoglobulin-like receptor (KIR) gene family.Crit Rev Immunol. 2002; 22: 463-482
- Allele-level haplotype frequencies and pairwise linkage disequilibrium for 14 KIR loci in 506 European-American individuals.PLoS One. 2012; 7: e47491
- Meiotic recombination generates rich diversity in NK cell receptor genes, alleles, and haplotypes.Genome Res. 2009; 19: 757-769
- Distinct diversity of KIR genes in three southern Indian populations: comparison with world populations revealed a link between KIR gene content and pre-historic human migrations.Immunogenetics. 2008; 60: 207-217
- New allele frequency database: http://www.allelefrequencies.net.Tissue Antigens. 2003; 61: 403-407
- Distribution of killer cell immunoglobulin-like receptor genes in the Chinese Han population.Tissue Antigens. 2005; 65: 556-563
- Predominance of group A KIR haplotypes in Japanese associated with diverse NK cell repertoires of KIR expression.Immunogenetics. 2002; 54: 543-550
- Haplotype analysis of killer cell immunoglobulin-like receptor genes in 77 Korean families.Hum Immunol. 2005; 66: 146-154
- High KIR diversity in Amerindians is maintained using few gene-content haplotypes.Immunogenetics. 2006; 58: 474-480
- Amazonian Amerindians exhibit high variability of KIR profiles.Immunogenetics. 2007; 59: 625-630
- Genomic diversity of natural killer cell receptor genes in three populations.Tissue Antigens. 2001; 57: 358-362
- Distinctive KIR and HLA diversity in a panel of north Indian Hindus.Immunogenetics. 2002; 53: 1009-1019
- Comparison of the rapidly evolving KIR locus in Parsis and natives of India.Immunogenetics. 2008; 60: 121-129
- Unusual selection on the KIR3DL1/S1 natural killer cell receptor in Africans.Nat Genet. 2007; 39: 1092-1099
- Different NK cell surface phenotypes defined by the DX9 antibody are due to KIR3DL1 gene polymorphism.J Immunol. 2001; 166: 2992-3001
- Nature of allelic sequence polymorphism at the KIR3DL3 locus.Immunogenetics. 2006; 58: 614-627
- Seventeen novel alleles add to the already extensive KIR3DL3 diversity.Tissue Antigens. 2007; 70: 449-454
- Roles for HLA and KIR polymorphisms in natural killer cell repertoire selection and modulation of effector function.J Exp Med. 2006; 203: 633-645
- Direct binding and functional transfer of NK cell inhibitory receptors reveal novel patterns of HLA-C allotype recognition.J Immunol. 1998; 161: 571-577
- A single polymorphism disrupts the killer Ig-like receptor 2DL2/2DL3 D1 domain.J Immunol. 2006; 177: 5347-5357
- Functional polymorphism of the KIR3DL1/S1 receptor on human NK cells.J Immunol. 2007; 178: 235-241
- KIR3DL1 polymorphisms that affect NK cell inhibition by HLA-Bw4 ligand.J Immunol. 2005; 175: 5222-5229
- Significant functional heterogeneity among KIR2DL1 alleles and a pivotal role of arginine 245.Blood. 2009; 114: 5182-5190
- Mutation at positively selected positions in the binding site for HLA-C shows that KIR2DL1 is a more refined but less adaptable NK cell receptor than KIR2DL3.J Immunol. 2012; 189: 1418-1430
- Allelic variation of killer cell immunoglobulin-like receptor 2DS5 impacts glycosylation altering cell surface expression levels.Hum Immunol. 2014; 75: 124-128
- The protein made from a common allele of KIR3DL1 (3DL1*004) is poorly expressed at cell surfaces due to substitution at positions 86 in Ig domain 0 and 182 in Ig domain 1.J Immunol. 2003; 171: 6640-6649
- The HLA system. Second of two parts.N Engl J Med. 2000; 343: 782-786
- The HLA system. First of two parts.N Engl J Med. 2000; 343: 702-709
- Alloantigen recognition by two human natural killer cell clones is associated with HLA-C or a closely linked gene.Proc Natl Acad Sci U S A. 1992; 89: 7983-7985
- HLA-C is the inhibitory ligand that determines dominant resistance to lysis by NK1- and NK2-specific natural killer cells.Proc Natl Acad Sci U S A. 1993; 90: 12000-12004
- Molecular clones of the p58 NK cell receptor reveal immunoglobulin-related molecules with diversity in both the extra- and intracellular domains.Immunity. 1995; 2: 439-449
- A single amino acid in the p58 killer cell inhibitory receptor controls the ability of natural killer cells to discriminate between the two groups of HLA-C allotypes.J Immunol. 1997; 158: 4026-4028
- The Bw4 public epitope of HLA-B molecules confers reactivity with natural killer cell clones that express NKB1, a putative HLA receptor.J Exp Med. 1995; 181: 1133-1144
- NK3-specific natural killer cells are selectively inhibited by Bw4-positive HLA alleles with isoleucine 80.J Exp Med. 1994; 180: 1235-1242
- Cutting edge: allele-specific and peptide-dependent interactions between KIR3DL1 and HLA-A and HLA-B.J Immunol. 2007; 178: 33-37
- The natural killer cell receptor specific for HLA-A allotypes: a novel member of the p58/p70 family of inhibitory receptors that is characterized by three immunoglobulin-like domains and is expressed as a 140-kD disulphide-linked dimer.J Exp Med. 1996; 184: 505-518
- A human killer inhibitory receptor specific for HLA-A1,2.J Immunol. 1996; 156: 3098-3101
- Recognition of HLA-A3 and HLA-A11 by KIR3DL2 is peptide-specific.Eur J Immunol. 2004; 34: 1673-1679
- MHC class I-specific inhibitory receptors and their ligands structure diverse human NK-cell repertoires toward a balance of missing self-response.Blood. 2008; 112: 2369-2380
- Co-evolution of NK receptors and HLA ligands in humans is driven by reproduction.Immunol Rev. 2015; 267: 283-297
- Activation of NK cells by an endocytosed receptor for soluble HLA-G.PLoS Biol. 2006; 4: e9
- KIR2DL4 (CD158d), an NK cell-activating receptor with inhibitory potential.J Immunol. 2002; 168: 6208-6214
- SHP-1- and phosphotyrosine-independent inhibitory signaling by a killer cell Ig-like receptor cytoplasmic domain in human NK cells.J Immunol. 2002; 168: 5047-5057
- The influence of HLA genotype on AIDS.Annu Rev Med. 2003; 54: 535-551
- Natural killer cells expressing the KIR2DS1-activating receptor efficiently kill T-cell blasts and dendritic cells: implications in haploidentical HSCT.Blood. 2011; 117: 4284-4292
- KIR2DS1-positive NK cells mediate alloresponse against the C2 HLA-KIR ligand group in vitro.J Immunol. 2007; 179: 854-868
- Chimpanzees use more varied receptors and ligands than humans for inhibitory killer cell Ig-like receptor recognition of the MHC-C1 and MHC-C2 epitopes.J Immunol. 2009; 182: 3628-3637
- Recognition of peptide-MHC class I complexes by activating killer immunoglobulin-like receptors.Proc Natl Acad Sci U S A. 2005; 102: 13224-13229
- Crystal structure of the human natural killer cell activating receptor KIR2DS2 (CD158j).J Exp Med. 2003; 197: 933-938
- Human NK cell receptors/markers: a tool to analyze NK cell development, subsets and function.Cytometry A. 2013; 83: 702-713
- Functionally and structurally distinct NK cell receptor repertoires in the peripheral blood of two human donors.Immunity. 1997; 7: 739-751
- Analyses of HLA-C-specific KIR repertoires in donors with group A and B haplotypes suggest a ligand-instructed model of NK cell receptor acquisition.Blood. 2011; 117: 98-107
- Lineage-specific transition of histone signatures in the killer cell Ig-like receptor locus from hematopoietic progenitor to NK cells.J Immunol. 2008; 180: 418-425
- Cutting edge: KIR antisense transcripts are processed into a 28-base PIWI-like RNA in human NK cells.J Immunol. 2010; 185: 2009-2012
- Regulation of the natural killer cell receptor repertoire.Annu Rev Immunol. 2001; 19: 291-330
- Human NK cell education by inhibitory receptors for MHC class I.Immunity. 2006; 25: 331-342
- Licensing of natural killer cells by host major histocompatibility complex class I molecules.Nature. 2005; 436: 709-713
- How do natural killer cells find self to achieve tolerance?.Immunity. 2006; 24: 249-257
- Self-tolerance of natural killer cells.Nat Rev Immunol. 2006; 6: 520-531
- Receptor-ligand analyses define minimal killer cell Ig-like receptor (KIR) in humans.Immunogenetics. 2007; 59: 1-15
- Rejection of class I MHC-deficient haemopoietic cells by irradiated MHC-matched mice.Nature. 1991; 349: 329-331
- Tolerance of NK and LAK activity for HLA class I-deficient targets in a TAP1-deficient patient (bare lymphocyte syndrome type I).Hum Immunol. 1999; 60: 32-40
- Hierarchy of the human natural killer cell response is determined by class and quantity of inhibitory receptors for self-HLA-B and HLA-C ligands.J Immunol. 2007; 179: 5977-5989
- KIR and disease: a model system or system of models?.Immunol Rev. 2006; 214: 186-201
- The Yin and Yang of HLA and KIR in human disease.Semin Immunol. 2008; 20: 343-352
- Human diversity of killer cell immunoglobulin-like receptors and disease.Korean J Hematol. 2011; 46: 216-228
- Natural killer cells in antiviral defense: function and regulation by innate cytokines.Annu Rev Immunol. 1999; 17: 189-220
- Natural killer cells in human health and disease.Clin Immunol. 2006; 118: 1-10
- Natural killer cell deficiency.J Allergy Clin Immunol. 2013; 132 ([quiz: 26]): 515-525
- Control of HIV-1 viremia and protection from AIDS are associated with HLA-Bw4 homozygosity.Proc Natl Acad Sci U S A. 2001; 98: 5140-5145
- Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS.Nat Genet. 2002; 31: 429-434
- Recovery, persistence, and sequelae in hepatitis C virus infection: a perspective on long-term outcome.Semin Liver Dis. 2000; 20: 17-35
- HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection.Science. 2004; 305: 872-874
- NK cells and cancer immunosurveillance.Oncogene. 2008; 27: 5932-5943
- NK cells and cancer.J Immunol. 2007; 178: 4011-4016
- Hierarchy of resistance to cervical neoplasia mediated by combinations of killer immunoglobulin-like receptor and human leukocyte antigen loci.J Exp Med. 2005; 201: 1069-1075
- Protective effect of the HLA-Bw4I80 epitope and the killer cell immunoglobulin-like receptor 3DS1 gene against the development of hepatocellular carcinoma in patients with hepatitis C virus infection.J Infect Dis. 2005; 192: 162-165
- Killer cell immunoglobulin-like receptor gene-cluster 3DS1-2DL5-2DS1-2DS5 predisposes susceptibility to Vogt-Koyanagi-Harada syndrome in Japanese individuals.Hum Immunol. 2010; 71: 192-194
- The current status of hematopoietic cell transplantation.Annu Rev Med. 2003; 54: 491-512
- Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants.Science. 2002; 295: 2097-2100
- Donors with group B KIR haplotypes improve relapse-free survival after unrelated hematopoietic cell transplantation for acute myelogenous leukemia.Blood. 2009; 113: 726-732
- KIR ligands and prediction of relapse after unrelated donor hematopoietic cell transplantation for hematologic malignancy.Biol Blood Marrow Transplant. 2006; 12: 828-836
- Donor KIR genes 2DL5A, 2DS1 and 3DS1 are associated with a reduced rate of leukaemia relapse after HLA-identical sibling stem cell transplantation for acute myeloid Leukaemia but not other haematological malignancies.Biol Blood Marrow Transplant. 2010; 16: 1257-1264
- Donor selection for natural killer cell receptor genes leads to superior survival after unrelated transplantation for acute myelogenous leukemia.Blood. 2010; 116: 2411-2419
Article info
Footnotes
Disclosure: The author has nothing to disclose.
Identification
Copyright
© 2018 Elsevier Inc. All rights reserved.
